Real-life experience with remdesivir for treatment of COVID-19 among older adults: a multicentre retrospective study.

Ili MargalitGiusy TiseoMarco RipaVanni BorghiHefziba GreenVirginie PrendkiNiccolò RiccardiGiovanni Battista PeregoAlessandro GrembialeLaura GalliMarco TinelliAntonella CastagnaCristina MussiniMarco Falcone Dafna Yahav

Published in: The Journal of antimicrobial chemotherapy (2023)

Among elderly individuals hospitalized with COVID-19, remdesivir carries survival benefit for those with moderate to severe disease. Its role among individuals with critical illness should be further assessed.

Keyphrases

coronavirus disease
sars cov
clinical trial
early onset
high intensity
respiratory syndrome coronavirus
cross sectional
randomized controlled trial
middle aged
combination therapy
double blind
free survival